Orchestra BioMed Holdings (OBIO) Non-Current Assets (2020 - 2026)

Orchestra BioMed Holdings (OBIO) has reported Non-Current Assets for 7 consecutive years, with $4.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Assets fell 37.76% year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at $25.4 million (down 5.37% YoY), while the FY2025 annual figure was $6.9 million, down 0.8% from the prior year.
• Non-Current Assets slipped to $4.4 million in Q1 2026 per OBIO's latest filing, from $6.9 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $160.2 million in Q2 2022 and bottomed at $4.4 million in Q1 2026.
• Historically, Non-Current Assets has averaged $28.4 million across 5 years, with a median of $6.9 million in 2025.
• Annual changes were most pronounced in 2023 — Non-Current Assets tumbled 96.07% — and 2025, when it gained 17.64%.
• Orchestra BioMed Holdings' Non-Current Assets stood at $10.9 million in 2022, then slumped by 43.96% to $6.1 million in 2023, then grew by 14.82% to $7.0 million in 2024, then dropped by 0.8% to $6.9 million in 2025, then sank by 35.95% to $4.4 million in 2026.
• Business Quant data shows OBIO's Non-Current Assets at $4.4 million in Q1 2026, $6.9 million in Q4 2025, and $7.0 million in Q3 2025.